Community-Acquired Bacterial Pneumonia medicine

NEW DELHI: India has achieved a big breakthrough with the creation of Nafithromycin, a new antibiotic marketed as Miqnaf, to handle severe cases of sepsis, bacterial and viral infections. This new antibiotic, targets Community-Acquired Bacterial Pneumonia (CABP), a condition that causes over 2 million fatalities globally each year and will help in fight against antimicrobial resistance […]